References
Baldo G, Wu S, Howe RA, Ramamoothy M, Knutsen RH, Fang J, Mecham RP, Liu Y, Wu X, Atkinson JP et al (2011) Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation. Mol Genet Metab 104:608–19. doi:10.1016/j.ymgme.2011.08.018
Osborn MJ, Webber BR, McElmurry RT, Rudser KD, DeFeo AP, Muradian M, Petryk A, Hallgrimsson B, Blazar BR, Tolar J et al (2016) Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology. J Inherit Metab Dis. doi:10.1007/s10545-016-9988-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Esteban Alberto Gonzalez, Angela Maria Vicente Tavares, Edina Poletto, Roberto Giugliani, Ursula Matte, and Guilherme Baldo declare that they have no conflict of interest.
Animal rights
All institutional and national guidelines for the care and use of laboratory animals were followed.
Additional information
Communicated by: Carla E. Hollak
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 838 kb)
Rights and permissions
About this article
Cite this article
Gonzalez, E.A., Tavares, A.M.V., Poletto, E. et al. Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I. J Inherit Metab Dis 40, 311–312 (2017). https://doi.org/10.1007/s10545-017-0014-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-017-0014-x